Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

307
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

459
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
459
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

737
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
737
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

559
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
559
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Science and Clinical Application of Nutrition to Coronary Heart Disease.

Journal of the American College of Nutrition·2018
Same author

Preoperative cardiac evaluation.

Postgraduate medicine·2017
Same author

Central venous catheters.

Postgraduate medicine·2017
Same author

Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.

The American journal of cardiology·2007
Same author

Stress testing in patients with implantable cardioverter-defibrillators: a preliminary report.

Preventive cardiology·2007
Same author

Outcome of ventricular fibrillation developing during percutaneous coronary interventions in 19,497 patients without cardiogenic shock.

The American journal of cardiology·2005

Related Experiment Video

Updated: Feb 17, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.3K

Reversing coronary atherosclerosis.

Joel K Kahn

    Postgraduate Medicine
    |December 9, 2017
    PubMed
    Summary

    New trial results suggest current atherosclerosis treatments, including standard diets and lipid-lowering therapies, may be insufficient. More aggressive approaches to managing hyperlipidemia are being explored to potentially reverse coronary artery narrowing.

    Area of Science:

    • Cardiovascular Medicine
    • Atherosclerosis Research
    • Lipidology

    Background:

    • Established coronary artery disease may progress despite adherence to standard dietary recommendations.
    • Current lipid-lowering therapy targets may not be sufficient to reverse coronary artery narrowing.

    Purpose of the Study:

    • To review recent findings on atherosclerosis treatment.
    • To evaluate the impact of aggressive hyperlipidemia management on coronary atherosclerosis.
    • To discuss the clinical applications of these findings.

    Main Methods:

    • Review of completed and ongoing clinical trials.
    • Analysis of studies employing intensive lipid-lowering strategies.
    • Examination of effects on coronary atherosclerosis progression and regression.

    More Related Videos

    Author Spotlight: Enhancing Coronary Artery Revascularization
    05:25

    Author Spotlight: Enhancing Coronary Artery Revascularization

    Published on: September 15, 2023

    1.3K
    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
    04:30

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

    Published on: May 14, 2013

    26.4K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
    13:10

    Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

    Published on: April 24, 2017

    19.3K
    Author Spotlight: Enhancing Coronary Artery Revascularization
    05:25

    Author Spotlight: Enhancing Coronary Artery Revascularization

    Published on: September 15, 2023

    1.3K
    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
    04:30

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

    Published on: May 14, 2013

    26.4K

    Main Results:

    • Standard dietary interventions may not halt atherosclerosis progression.
    • Current lipid goals may be inadequate for reversing coronary narrowing.
    • Aggressive hyperlipidemia control shows potential in managing atherosclerosis.

    Conclusions:

    • Rethinking current treatment paradigms for atherosclerosis is necessary.
    • More aggressive lipid management strategies warrant consideration.
    • Clinical application of novel approaches may improve outcomes for coronary artery disease.